Versions :<1234567Live

Study: Superbugs Could Cost Global Economy $1.7T by 2050

Above: Methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image copyright: Unsplash

The Spin

Narrative A

Federal aid cuts are dangerously shortsighted, given that antimicrobial resistance poses a significant threat to global security. The economic modeling shows that every dollar invested in AMR prevention delivers a 28:1 return, making these programs among the most cost-effective interventions available. Cutting international AMR surveillance now virtually guarantees higher resistance rates worldwide, ultimately costing developed nations far more in the long run.

Narrative B

Fiscal responsibility requires tough choices, and domestic priorities must take precedence during challenging economic times. The partnerships and expertise from programs like the Fleming Fund will continue even without direct funding, allowing countries to develop their own surveillance capabilities. Defense spending increases are essential for national security, and the private sector can play a crucial role in filling gaps in global health initiatives.

Metaculus Prediction

There's an 8% chance that the number of deaths from antibiotic-resistant infections per year will double by Dec. 31, 2025, according to the Metaculus prediction community.


Editor's Note

This story currently has limited coverage. We will continue to monitor all major outlets and update our reporting as additional information becomes available.

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!